Back to Search
Start Over
MAGELLAN-1, Part 2: Glecaprevir and Pibrentasvir for 12 or 16 Weeks in Patients with Chronic HCV Genotype 1 or 4 and Prior Direct-Acting Antiviral Treatment Failure
- Source :
- Gastroenterology. 152:S1057
- Publication Year :
- 2017
- Publisher :
- Elsevier BV, 2017.
Details
- ISSN :
- 00165085
- Volume :
- 152
- Database :
- OpenAIRE
- Journal :
- Gastroenterology
- Accession number :
- edsair.doi...........5cf9e99815ee7703f9c0358564fa5a97